Search Results - "Konings, Inge R."

Presenting decision-relevant numerical information to Dutch women aged 50-70 with varying levels of health literacy: Case example of adjuvant systemic therapy for breast cancer by van Strien-Knippenberg, Inge S, Timmermans, Daniëlle R M, Engelhardt, Ellen G, Konings, Inge R H M, Damman, Olga C

“…If communicated adequately, numerical decision-relevant information can support informed and shared decision making. Visual formats are recommended, but which…”
Get full text

Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands by de Blok, Christel J M, Wiepjes, Chantal M, Nota, Nienke M, van Engelen, Klaartje, Adank, Muriel A, Dreijerink, Koen M A, Barbé, Ellis, Konings, Inge R H M, den Heijer, Martin

“…AbstractObjectiveTo investigate the incidence and characteristics of breast cancer in transgender people in the Netherlands compared with the general Dutch…”
Get full text

Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial-a study protocol by Civil, Yasmin A, Oei, Arlene L, Duvivier, Katya M, Bijker, Nina, Meijnen, Philip, Donkers, Lorraine, Verheijen, Sonja, van Kesteren, Zdenko, Palacios, Miguel A, Schijf, Laura J, Barbé, Ellis, Konings, Inge R H M, -van der Houven van Oordt, C Willemien Menke, Westhoff, Paulien G, Meijer, Hanneke J M, Diepenhorst, Gwen M P, Thijssen, Victor, Mouliere, Florent, Slotman, Berend J, van der Velde, Susanne, van den Bongard, H J G Desirée

“…Partial breast irradiation (PBI) is standard of care in low-risk breast cancer patients after breast-conserving surgery (BCS). Pre-operative PBI can result in…”
Get full text

Predictors for use of psychosocial services in patients with metastatic colorectal cancer receiving first line systemic treatment by Schuurhuizen, Claudia S E W, Braamse, Annemarie M J, Konings, Inge R H M, Verheul, Henk M W, Dekker, Joost

“…Patients with advanced disease experience high levels of psychological distress, yet there is low uptake of psychosocial services offered to patients who…”
Get full text

Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels by Jongbloed, Elisabeth M., Jansen, Maurice P. H. M., de Weerd, Vanja, Helmijr, Jean A., Beaufort, Corine M., Reinders, Marcel J. T., van Marion, Ronald, van IJcken, Wilfred F. J., Sonke, Gabe S., Konings, Inge R., Jager, Agnes, Martens, John W. M., Wilting, Saskia M., Makrodimitris, Stavros

“…Next generation sequencing of cell-free DNA (cfDNA) is a promising method for treatment monitoring and therapy selection in metastatic breast cancer (MBC)…”
Get full text

Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling by Angus, Lindsay, Smid, Marcel, Wilting, Saskia M., Bos, Manouk K., Steeghs, Neeltje, Konings, Inge R. H. M., Tjan-Heijnen, Vivianne C. G., van Riel, Johanna M. G. H., van de Wouw, Agnes J., Cuppen, Edwin, Lolkema, Martijn P., Jager, Agnes, Sleijfer, Stefan, Martens, John W. M.

“…Mutations in the estrogen receptor gene (ESR1), its transcriptional regulators, and the mitogen-activated protein kinase (MAPK) pathway are enriched in…”
Get full text

The addition of pravastatin to chemotherapy in advanced gastric carcinoma: A randomised phase II trial by Konings, Inge R.H.M, van der Gaast, A, van der Wijk, Lidemarie J, de Jongh, Felix E, Eskens, Ferry A.L.M, Sleijfer, Stefan

“…Abstract Purpose Statins have for long been considered to play a potential role in anticancer treatment based upon their ability to inhibit the mevalonate…”
Get full text

Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials by van der Vorst, Maurice J. D. L, Neefjes, Elisabeth C. W., Konings, Inge R. H. M., Verheul, Henk M. W.

“…Purpose Delayed chemotherapy-induced nausea and vomiting (CINV) remains an important adverse effect of moderately emetogenic chemotherapy not containing…”
Get full text

Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study by Konings, Inge R. H. M., Sleijfer, Stefan, Mathijssen, Ron H. J., de Bruijn, Peter, Ghobadi Moghaddam-Helmantel, Inge M., van Dam, Linda M., Wiemer, Erik A. C., Verweij, Jaap, Loos, Walter J.

“…Purpose Response to anticancer therapy is believed to be directly related to the concentration of the anticancer drug in the tumor itself. Assessment of…”
Get full text

The meaning-making process in the re-entry phase: A qualitative focus group study with patients treated for breast cancer or melanoma by Visser, Anna, Post, Lenneke, Dekker, Joost, van Zuylen, Lia, Konings, Inge R.

“…After completion of curative cancer treatment patients enter the re-entry phase, which is characterized by the task to pick up life again. While having to…”
Get full text

Application of prolonged microdialysis sampling in carboplatin-treated cancer patients by Konings, Inge R. H. M, Engels, Frederike K, Sleijfer, Stefan, Verweij, Jaap, Wiemer, Erik A. C, Loos, Walter J

“…Purpose To better understand the mechanisms underlying (in)sensitivity of tumors to anticancer drugs, assessing intra-tumor drug pharmacokinetics (PKs) could…”
Get full text

Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: A prospective cross-over drug–drug interaction study by van der Bol, Jessica M, Loos, Walter J, de Jong, Floris A, van Meerten, Esther, Konings, Inge R.H.M, Lam, Mei H, de Bruijn, Peter, Wiemer, Erik A.C, Verweij, Jaap, Mathijssen, Ron H.J

“…Abstract Background Omeprazole is one of the most prescribed medications worldwide and within the class of proton pump inhibitors, it is most frequently…”
Get full text

Higher Muscle Strength Is Associated with Prolonged Survival in Older Patients with Advanced Cancer by Versteeg, Kathelijn Sophie, Blauwhoff‐Buskermolen, Susanne, Buffart, Laurien M., de van der Schueren, Marian A.E., Langius, Jacqueline A.E., Verheul, Henk M.W., Maier, Andrea B., Konings, Inge R.

“…Background Identifying predictors of treatment toxicity and overall survival (OS) is important for selecting patients who will benefit from chemotherapy. In…”
Get full text

Tailoring exercise interventions to comorbidities and treatment-induced adverse effects in patients with early stage breast cancer undergoing chemotherapy: a framework to support clinical decisions by van der Leeden, Marike, Huijsmans, Rosalie J., Geleijn, Edwin, de Rooij, Mariëtte, Konings, Inge R., Buffart, Laurien M., Dekker, Joost, Stuiver, Martijn M.

“…Purpose: Delivery of exercise interventions to patients with early-stage breast cancer undergoing chemotherapy requires complex clinical decisions. The purpose…”
Get full text

Post-operative re-irradiation with hyperthermia in locoregional breast cancer recurrence: Temperature matters by Bakker, Akke, Tello Valverde, C. Paola, van Tienhoven, Geertjan, Kolff, M. Willemijn, Kok, H. Petra, Slotman, Ben J., Konings, Inge R.H.M., Oei, Arlene L., Oldenburg, Hester S.A., Rutgers, Emiel J.T., Rasch, Coen R.N., van den Bongard, H.J.G. Desirée, Crezee, Hans

“…•Postoperative re-irradiation and hyperthermia is effective in recurrent breast cancer.•CEM43T50 incorporates both hyperthermia treatment duration and median…”
Get full text

Information and communication priorities of patients and healthcare professionals in shared decision making regarding adjuvant systemic breast cancer treatment: A survey study by Damman, Olga C., van Strien-Knippenberg, Inge S., Engelhardt, Ellen G., Determann D, Domino, de Bruijne, Martine C., Siesling, Sabine, Konings, Inge R., Timmermans, Danielle R.

“…To assess information and communication priorities of patients and healthcare professionals in Shared Decision Making about adjuvant systemic treatment of…”
Get full text

Muscle contractile properties of cancer patients receiving chemotherapy: Assessment of feasibility and exercise effects by Buffart, Laurien M., Sweegers, Maike G., Ruijter, Cornelis J., Konings, Inge R., Verheul, Henk M.W., Zweeden, Annette A., Grootscholten, Cecile, Chinapaw, Mai J., Altenburg, Teatske M.

“…Background This pilot trial explores the feasibility of measuring muscle contractile properties in patients with cancer, effects of exercise during…”
Get full text

Economic evaluation of a combined screening and stepped-care treatment program targeting psychological distress in patients with metastatic colorectal cancer: A cluster randomized controlled trial by El Alili, Mohamed, Schuurhuizen, Claudia S.E.W, Braamse, Annemarie M.J., Beekman, Aartjan T.F., van der Linden, Mecheline H., Konings, Inge R., Dekker, Joost, Bosmans, Judith E.

“…Background: Psychological distress is highly prevalent among patients with metastatic colorectal cancer. Aims: To perform an economic evaluation of a combined…”
Get full text

High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2− postmenopausal breast cancer patients treated with everolimus and exemestane by Kruger, Dinja T., Jansen, Maurice P.H.M., Konings, Inge R.H.M., Dercksen, Wouter M., Jager, Agnes, Oulad Hadj, Jamal, Sleijfer, Stefan, Martens, John W.M., Boven, Epie

“…We determined whether progression‐free survival (PFS) in metastatic breast cancer (MBC) patients receiving everolimus plus exemestane (EVE/EXE) varies…”
Get full text

Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis by Werter, Inge M, Remmelzwaal, Sharon, Burchell, George L, de Gruijl, Tanja D, Konings, Inge R, van der Vliet, Hans J, Menke-van der Houven van Oordt, C Willemien

“…Patients with HER2-positive (HER2+) metastatic breast cancer (mBC) develop brain metastases (BM) in up to 30% of cases. Treatment of patients with BM can…”
Get full text